Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Meetu Dahiya"'
Autor:
Nupur Das, Meetu Dahiya, Ritu Gupta, Lalit Kumar, Lata Rani, Anubha Gupta, Akanksha Farswan, Atul Sharma, Om Dutt Sharma
Publikováno v:
American Journal of Clinical Pathology. 159:69-80
Objectives With a substantial number of patients with multiple myeloma (MM) experiencing disease relapse, the quest for more sensitive methods to assess deeper responses indicative of cure continues. Methods In this prospective analysis of 170 patien
Autor:
Nupur Das, Meetu Dahiya, Ritu Gupta, Sandeep Rai, Saroj Singh, Vijay K. Prajapati, Lalit Kumar, Atul Sharma, Ranjit K. Sahoo, Ajay Gogia
Publikováno v:
Cytometry Part B: Clinical Cytometry. 102:292-302
The expression pattern of common antigens including cytoplasmic kappa/lambda ratio (cyKLR) was evaluated by flow cytometric immunophenotyping (FCMI) to explore their relevance in discriminating normal and aberrant plasma cells (NPC and APC, respectiv
Autor:
Nupur Das, Meetu Dahiya, Ritu Gupta, Lalit Kumar, Atul Sharma, Sandeep Rai, Saroj Singh, Vijay K. Prajapati, Ranjit K. Sahoo, Ajay Gogia
Publikováno v:
Cytometry. Part B, Clinical cytometryREFERENCES. 102(3)
Immunophenotypic profile and post-therapy alteration in antigenic expression were evaluated in normal, reactive, and aberrant plasma cells (NPC, RPC, and APC) for impact on measurable residual disease (MRD) assessment in multiple myeloma (MM).Samples
Autor:
Meetu Dahiya, Vijay k. Prajapati, Ritu Gupta, Lalit Kumar, Sandeep Rai, Saroj Singh, Ranjit Sahoo, Ajay Gogia, Nupur Das, Atul Sharma
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S436-S437
Context A deeper understanding of the normal plasma cell (PC) compartment and changes in the immunophenotypic profile post-treatment is required to assess low levels of residual disease in multiple myeloma (MM) using multiparametric flow cytometry. O
Autor:
Om Dutt Sharma, Atul Sharma, Ritu Gupta, Lakshmy Ramakrishnan, Varun Shekhar, Meetu Dahiya, Lalit Kumar, Abida Begum
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:e345-e350
Background We sought to determine the prevalence of monoclonal gammopathy of undetermined significance (MGUS) in a hospital-based cohort in India. Patients and Methods From March 2015 to May 2015, 3429 patients (age range, 40-88 years) were enrolled
Autor:
Sadaf Khan, Meetu Dahiya, Anjali Mookerjee, Nitin Mathur, Lata Rani, Lalit Kumar, Ritu Gupta, Atul Sharma, Om Dutt Sharma, Varun Shekhar, Gurvinder Kaur
Publikováno v:
Annals of Hematology. 97:2447-2454
The recently introduced Revised International Staging System (R-ISS) for multiple myeloma (MM) integrates albumin, β2 microglobulin, lactate dehydrogenase (LDH) with high-risk cytogenetic aberrations (CA), i.e., t(4;14) and t(14;16) and del17p using
Autor:
Ranjit Sahoo, Vijay k. Prajapati, Nupur Das, Sandeep Rai, Atul Sharma, Meetu Dahiya, Ritu Gupta, Lalit Kumar, Ajay Gogia, Saroj Singh
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S438
Context The discriminative power of various antigens for delineating normal plasma cells (NPC) from aberrant plasma cells (APC) is variable; thus, understanding of the multiparametric flow cytometry (MFC)-based PC compartment is crucial for reliable
Autor:
Nupur Das, Ritu Gupta, Meetu Dahiya, Sandeep Rai, Saroj Singh, Vijay K. Prajapati, Ranjit K Sahoo, Ajay Gogia, Atul Sharma, Lalit Kumar
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S256
Autor:
Ritu Gupta, Nupur Das, Meetu Dahiya, Sandeep Rai, Saroj Singh, Vijay K. Prajapati, Ranjit k. Sahoo, Ajay Gogia, Atul Sharma, Lalit Kumar
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S256
Autor:
Om Dutt Sharma, Lalit Kumar, Meetu Dahiya, Ritu Gupta, Varun Shekhar, Atul Sharma, P. Harish, Nitin Mathur
Publikováno v:
Leukemia & Lymphoma. 58:1234-1237
The use of novel agents for the treatment of multiple myeloma (MM) has enabled attainment of deeper responses and the information that progression-free survival (PFS) and overall survival (OS) corr...